• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Monument Therapeutics

To add a bio or update company history, please click update information.

News from Monument Therapeutics

    Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988
    Monument Therapeutics
    25 Feb 2025

    Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988

    Monument Therapeutics applies digital biomarkers to psychiatric drug development, advancing combination therapies designed to improve cognitive impairment in schizophrenia alongside existing antipsychotic treatments.

Monument Therapeutics
  • Life Sciences
  • Manchester, United Kingdom
  • £850k
  • monumenttx.com
  • Update Information

More venture news

  • Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
    Sequential Bio
    17 Mar 2026

    Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients

    EquityLife Sciences
  • Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
    Ternary Therapeutics
    16 Mar 2026

    Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

    SeedLife Sciences
  • BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
    BIOCAPTIVA
    9 Mar 2026

    BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn